oxybutynin has been researched along with Cardiac Hypertrophy in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herbst, J | 1 |
| Gilbert, JD | 1 |
| Byard, RW | 1 |
1 other study available for oxybutynin and Cardiac Hypertrophy
| Article | Year |
|---|---|
Urinary incontinence, hyperthermia, and sudden death.
Topics: Aged, 80 and over; Cardiomegaly; Cholinergic Antagonists; Death, Sudden; Exercise; Female; Fever; Fo | 2011 |